Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
ClinicalTrials.gov study NCT01891357. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
ClinicalTrials.gov study NCT02892734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT01873833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
ClinicalTrials.gov study NCT03304080. IPD Sharing: YES. Countries: 1. Publications: 0.
Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC
ClinicalTrials.gov study NCT05198856. IPD Sharing: NO. Countries: 0. Publications: 9.
Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
ClinicalTrials.gov study NCT00426556. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Tucatinib With Brain and/or Spinal XRT in Patients With HER2+ Metastatic Breast Cancer and LMD
ClinicalTrials.gov study NCT06016387. IPD Sharing: NO. Countries: 1. Publications: 0.
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT06439693. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.
ClinicalTrials.gov study NCT01290718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT00470847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT01276041. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
ClinicalTrials.gov study NCT03747120. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
ClinicalTrials.gov study NCT01353222. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer
ClinicalTrials.gov study NCT03289039. IPD Sharing: NO. Countries: 1. Publications: 0.
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy
ClinicalTrials.gov study NCT01922921. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02154529. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
ClinicalTrials.gov study NCT00431067. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00825734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
ClinicalTrials.gov study NCT00810017. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Patients With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00105456. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.